SCHEMBL8521006

SCHEMBL8521006

CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.82
▸ MAPT P10636 3/20 0.82
▸ MAPK1 P28482 3/20 0.82
▸ TDP1 Q9NUW8 2/20 0.82
▸ CYP3A4 P08684 2/20 0.82
▸ PMP22 Q01453 2/20 0.82
▸ NPSR1 Q6W5P4 2/20 0.82
▸ GLA P06280 1/20 0.82
▸ TSHR P16473 1/20 0.82
▸ EDNRA P25101 1/20 0.82
▸ HIF1A Q16665 1/20 0.82
▸ HSD17B10 Q99714 1/20 0.82
▸ PPARG P37231 12/20 0.78
▸ RXRA P19793 5/20 0.73
▸ PTGS2 P35354 2/20 0.69
▸ EGFR P00533 1/20 0.69
▸ ADORA3 P0DMS8 1/20 0.69
▸ DRD1 P21728 1/20 0.69
▸ PTGS1 P23219 1/20 0.69
▸ OPRM1 P35372 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Exisulind SCHEMBL25371 0.90 CYP1A2 (1.00) CYP1A2MAPTMAPK1TDP1CYP3A4
Exisulind SCHEMBL4776597 0.90 CYP1A2 (1.00) CYP1A2MAPTMAPK1TDP1CYP3A4
SCHEMBL30095195 0.90 PPARG (0.84) CYP1A2MAPTMAPK1TDP1CYP3A4
Exisulind SCHEMBL29395528 0.90 CYP1A2 (1.00) CYP1A2MAPTMAPK1TDP1CYP3A4
Exisulind SCHEMBL1651133 0.90 CYP1A2 (1.00) CYP1A2MAPTMAPK1TDP1CYP3A4
SCHEMBL24101477 0.90 PPARG (0.84) CYP1A2MAPTMAPK1TDP1CYP3A4
Exisulind SCHEMBL7634644 0.89 CYP1A2 (0.98) CYP1A2MAPTMAPK1TDP1CYP3A4
Exisulind SCHEMBL9711060 0.89 CYP1A2 (0.98) CYP1A2MAPTMAPK1TDP1CYP3A4
SCHEMBL10740005 0.88 CA12 (0.66) CYP1A2MAPTMAPK1TDP1CYP3A4
SCHEMBL7112872 0.87 CYP1A2 (0.78) CYP1A2MAPTMAPK1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 — — US disclosed
US-4656190-A PLATELET ACTIVATING FACTOR MERCK & CO., INC. (US) 1987-04-07 — — US disclosed
EP-0142801-A2 Indene derivatives useful as paf-antagonists MERCK & CO. INC. (US) 1985-05-29 — — EP disclosed
Send feedback